News
News from the BioCity Campus

CO.DON AG: Gradual return to normal operations

Over the past few weeks, CO.DON AG has seen a slow but steady increase in incoming orders in parallel with the gradual resumption of regular hospital operations.

In connection with the increasing spread of the corona virus, measures have been taken in all areas of the company since mid-March, which on the one hand protect the workforce from infection as best as possible and on the other hand ensure production continuity through agile raw material and inventory management. At the end of March, short-time work was introduced for the workforce of the German parent company, as there was a significant drop in orders compared to the same period of the previous year due to the Covid-19-justified contact restrictions and the Federal Government’s request to hospitals not to plan any elective surgeries for the time being.

Due to the positive development, CO.DON AG will relax the travel restrictions between the locations and return to the contractually agreed working time models in July 2020.

Tilmann Bur, CEO of CO.DON AG: "We are relieved and happy that a careful resumption of everyday work is now possible. Together with our business partners, we are confident that, as expected, we will be able to continue the good first quarter result of the current financial year. This gradual return to day-to-day business is of course accompanied by the implementation of hygiene and safety measures, which are essential for our sales team, but also for all other employees of our CO.DON.”

Source: Communication from CO.DON AG dated June 23.06.2020, XNUMX

 


previous news

New type of antibiotic for periodontitis treatment developed at the Fraunhofer IZI wins overall victory at the IQ Innovation Prize Central Germany

With PerioTrap Pharmaceuticals GmbH, a spin-off from the Fraunhofer Institute for Cell Therapy and Immunology IZI, a Fraunhofer development was awarded the cluster and overall prize at the IQ Innovation Prize Central Germany on June 25, 2020. A novel, locally applied antibiotic for the treatment of periodontitis received the award. With the IQ Innovation Prize Central Germany, the European metropolitan region of Central Germany promotes new, marketable products, processes and services to increase innovation and competitiveness of the region's economy.

NextNews

Neanderthal genes in a petri dish

Scientists are studying Neanderthal DNA in humans alive today using stem cells and organoids

Protocols for converting pluripotent stem cells (iPSCs) into organoids, mini-organs, allow researchers to study developmental processes in different organs and to unravel the connection between genes and tissue formation – especially in organs where primary tissue is not available.